Predictive Oncology completes $343.5 million financing to launch ATH token treasury strategy
BlockBeats News, October 8th, according to Globenewswire, Nasdaq-listed company Predictive Oncology announced that it has completed a $343.5 million PIPE financing. The company will use these funds to purchase ATH tokens on the open market to support its ATH token treasury strategy. ATH is the native utility token of the Aethir ecosystem.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Summit (SMMT.US) surges after-hours following $2 billions investment from AstraZeneca (AZN.US) and joint drug development collaboration
Cancer drug developer Summit Therapeutics announced that AstraZeneca will make a strategic equity investment of $2 billion, and both parties will jointly develop drugs.
Crypto prices
More
